금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
EU Locks In Plan To Triple Energy Storage Capacity By 2030
Europe desperately needs an energy storage revolution. As the region gets rocked by the third energy...
Oil Traders Stay Bearish Despite Deepening Middle East Disruptions
Despite continued hostilities in the Middle East and an expansion of the war to the Red Sea, oil tra...
S&P closes at record high as soft jobs report eases rate-hike concerns
STORY: U.S. stocks rallied on Friday, with the Dow gaining more than a quarter of a percent, the S&P...
Consolidated Water anticipates realizing more than $13M of remaining revenue from two PERC projects primarily in 2026
IceCure Medical GAAP EPS of $0.06, revenue of $911M
Why Intel’s stock is falling and guiding the chip sector toward its worst day of the year
Analysts note “buyer exhaustion” and market concerns about what the latest inflation data may mean for future data-center spending commitments.
America’s day of fiscal reckoning draws closer
Inflation just wiped out all the U.S. wage gains since Donald Trump was elected president.
US Equity Indexes Fall, Treasury Yields Jump Amid Hot Inflation Print
US equity indexes fell in Tuesday's midday trading as a hotter-than-expected inflation print for Apr
These Stocks Are Today’s Movers: Qualcomm, Intel, Micron, Zebra, Nvidia, Quantum Computing, GameStop, and More
Intel, Qualcomm, and Micron fall as investors opt to lock in profits following a breakneck rally in chip stocks.
Kao reports Q1 results: GAAP EPS of ¥68.53, net sales of ¥413.22B
Ark Restaurants signals new America opening in early July as Vegas sales fall about 11%
Rigetti Computing sinks as Needham sees customer traction 'increasing' after Q1 results
Wells Fargo spotlights three reasons that the bull market still has momentum
Google AI legend raises big money for startup targeting this cutting-edge goal
Demis Hassabis is the co-founder and CEO of Google’s DeepMind artificial-intelligence lab, which has spun out a startup called Isomorphic Labs to use AI to accelerate the creation of new drugs.